Latest News on First Trust Value Line 100 ETF (FVL) ETF

  • GlaxoSmithKline’s 1Q17 Estimates: Revenues Expected to Grow [April 25 2017 06:09 AM]
  • Analysts expect ~16.5% growth in GlaxoSmithKline’s (GSK) 1Q17 revenues to ~7.3 billion pounds following strong product launches, acquired products from Novartis (NVS), and improvement in the supply chain.... Read more about this First Trust Value Line 100 ETF (FVL) news

Looking for Market Opportunties?

Today's Most Active Stocks
Today's Biggest Price % Gainers
Today's Biggest Price % Losers
Today's Unusual Rising Volume Stocks
Today's Unusual Falling Volume Stocks
Research Reports
Earning Calendar
ETF Center